C-19 Vaccines for Babies
For nearly 4 months, the CDC has pinned to the top of its X feed a post that recommends new C-19 vaccines for “everyone 6 months and older.”
IN FACT, the core clinical trials for C-19 vaccines had to be 400,000 times larger than they actually were to determine if they save more young children than they kill. Moreover, these underpowered trials:
- excluded children apt to have serious adverse reactions to the vaccines but still found reactions like fevers up to 105.4 ºF, eye-rolling seizures, convulsions, limping, and a “severe” decline in white blood cells that creates the “risk of overwhelming infection.”
- did not enroll enough children to show any clinically meaningful benefits like preventing severe Covid-19 or hospitalization.
- largely excluded children with evidence of a prior Covid infection, which exaggerates the efficacy of the vaccines and may downplay their risks.
- had 1–3 months of blinded follow up for safety and efficacy, while the FDA and other health agencies said that one year should be the bare minimum.
The bulk of the facts above come directly from the FDA, often buried on webpages in long lists of documents with vague recurring names like “Decision Memorandum.”
